CLINICAL_TRIALS
trial_result
· 2019-02-19
Clinical Trial Update: Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors [Phase 2]
Summary
Phase 2 efficacy trial assessing a combination of sorafenib and cyclophosphamide in patients with neuroendocrine tumors. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Health Network, Toronto | Conditions: Neuroendocrine Tumors | Phase 2 | Status: COMPLETED | Results posted: 2019-02-19